IHS Chemical Week

Regions :: Western Europe :: Sweden

Lonza Signs Deal with Swedish Start-up

4:24 AM MDT | March 17, 2011 | Alex Scott

Lonza says it has signed a deal to provide development and cGMP manufacturing services for Athera (Solna, Sweden), a start-up biotech company. Financial terms were not disclosed. Athera is part of Karolinska Development (Solna), a group which has a portfolio of more than 40 pharmaceutical companies.   Lonza says it will initiate cell line and process development, using its GS Gene expression system for Athera’s monoclonal antibody, PC-mAb, a developmental drug intended for the treatment of patients with acute coronary syndrome (ACS). People with ACS...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Not an IHS Chemical Week subscriber yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine a year in print or digital format
  • Real time news and analysis on chemweek.com 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now


contact us | about us | privacy policy | sitemap

ihsCopyright © IHS, Inc.All rights reserved.Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa